Login to Your Account

Financings Roundup

Creabilis Raises $20M in Series B for Psoriasis Drug

By Cormac Sheridan

Wednesday, October 5, 2011
Creabilis SA raised €15 million (US$20 million) in a Series B round to advance a pipeline of three compounds in development for dermatology, inflammation and pain indications.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription